In this study, we introduce a hybrid nanozyme, termed Fe‐MOF/CP, composed of iron metal‐organic framework (Fe‐MOF) nanoparticles, biological ChOx, and PEGylation, for integrated ferroptosis‐immune tumor therapy. This evidence concerns the gene CP and neoplasm.